(AVPT) Avepoint - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 2.313m USD | Total Return: -43.3% in 12m
Avg Turnover: 18.0M
Qual. Beats: 0
Rev. Trend: 99.8%
Qual. Beats: 0
Warnings
Choppy
Tailwinds
No distinct edge detected
AvePoint, Inc. (AVPT) provides a cloud-native data management platform designed to secure and optimize collaborative environments. The company’s architecture supports organizations using major third-party cloud providers, primarily Microsoft, Salesforce, and Google. Its core offerings include the Confidence Platform, which features specialized suites for data governance, ransomware recovery, and the modernization of legacy systems into AI-ready SaaS experiences.
Operating within the Application Software sub-industry, AvePoint utilizes a Software-as-a-Service (SaaS) business model characterized by recurring revenue through license and maintenance fees. This sector is currently driven by the increasing complexity of multi-cloud environments and the necessity for automated compliance and data sovereignty tools. You can further analyze these market dynamics and valuation metrics on ValueRay.
Headquartered in Jersey City, New Jersey, the firm serves a global market spanning North America, EMEA, and the Asia Pacific. By integrating backup-as-a-service and lifecycle management, AvePoint addresses critical operational risks associated with digital transformation and employee engagement platforms.
- SaaS migration trends accelerate demand for Microsoft 365 data management solutions
- Expansion of AI-ready modernization suite drives high-margin subscription revenue growth
- Strategic partnerships with major cloud vendors diversify cross-platform service adoption
- Increasing enterprise data governance requirements bolster long-term recurring revenue stability
- Operating margin expansion hinges on scaling global cloud-native platform efficiency
| Net Income: 46.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 1.54 > 1.0 |
| NWC/Revenue: 68.07% < 20% (prev 68.32%; Δ -0.25% < -1%) |
| CFO/TA 0.15 > 3% & CFO 109.0m > Net Income 46.6m |
| Net Debt (-430.9m) to EBITDA (54.9m): -7.84 < 3 |
| Current Ratio: 2.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (226.1m) vs 12m ago 0.68% < -2% |
| Gross Margin: 73.68% > 18% (prev 75.36%; Δ -1.68% > 0.5%) |
| Asset Turnover: 66.57% > 50% (prev 58.28%; Δ 8.29% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.41 (Total Current Assets 562.2m - Total Current Liabilities 260.3m) / Total Assets 734.2m |
| B: -0.72 (Retained Earnings -531.3m / Total Assets 734.2m) |
| C: 0.07 (EBIT TTM 48.6m / Avg Total Assets 666.5m) |
| D: 1.49 (Book Value of Equity 438.8m / Total Liabilities 295.4m) |
| Altman-Z'' = 2.39 = BBB |
| DSRI: 0.99 (Receivables 100.4m/80.1m, Revenue 443.7m/349.0m) |
| GMI: 1.02 (GM 75.36% / 73.68%) |
| AQI: 0.91 (AQ_t 0.20 / AQ_t-1 0.21) |
| SGI: 1.27 (Revenue 443.7m / 349.0m) |
| TATA: -0.09 (NI 46.6m - CFO 109.0m) / TA 734.2m) |
| Beneish M = -2.88 (Cap -4..+1) = A |
As of June 07, 2026, the stock is trading at USD 10.74 with a total of 1,465,065 shares traded.
Over the past week, the price has changed by -1.56%,
over one month by +1.70%,
over three months by -4.87% and
over the past year by -43.32%.
Avepoint has received a consensus analysts rating of 4.38. Therefore, it is recommended to buy AVPT.
- StrongBuy: 5
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 16.1 | 50.2% |
P/E Trailing = 54.55
P/S = 5.2135
P/B = 5.281
Revenue TTM = 443.7m USD
EBIT TTM = 48.6m USD
EBITDA TTM = 54.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 13.3m USD (from shortLongTermDebtTotal, last quarter) (leases 13.3m already included)
Net Debt = -430.9m USD (calculated: Debt 13.3m - CCE 444.1m)
Enterprise Value = 1.88b USD (2.31b + Debt 13.3m - CCE 444.1m)
Interest Coverage Ratio = unknown (Ebit TTM 48.6m / Interest Expense TTM 0.0)
EV/FCF = 17.95x (Enterprise Value 1.88b / FCF TTM 104.9m)
FCF Yield = 5.57% (FCF TTM 104.9m / Enterprise Value 1.88b)
FCF Margin = 23.64% (FCF TTM 104.9m / Revenue TTM 443.7m)
Net Margin = 10.51% (Net Income TTM 46.6m / Revenue TTM 443.7m)
Gross Margin = 73.68% ((Revenue TTM 443.7m - Cost of Revenue TTM 116.8m) / Revenue TTM)
Gross Margin QoQ = 72.81% (prev 73.60%)
Tobins Q-Ratio = 2.56 (Enterprise Value 1.88b / Total Assets 734.2m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 13.3m)
Taxrate = 10.28% (5.36m / 52.2m)
NOPAT = 43.6m (EBIT 48.6m * (1 - 10.28%))
Current Ratio = 2.16 (Total Current Assets 562.2m / Total Current Liabilities 260.3m)
Debt / Equity = 0.03 (Debt 13.3m / totalStockholderEquity, last quarter 438.8m)
Debt / EBITDA = -7.84 (Net Debt -430.9m / EBITDA 54.9m)
Debt / FCF = -4.11 (Net Debt -430.9m / FCF TTM 104.9m)
Total Stockholder Equity = 456.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.99% (Net Income 46.6m / Total Assets 734.2m)
RoE = 10.20% (Net Income TTM 46.6m / Total Stockholder Equity 456.9m)
RoCE = 10.25% (EBIT 48.6m / Capital Employed (Total Assets 734.2m - Current Liab 260.3m))
RoIC = 9.65% (NOPAT 43.6m / Invested Capital 451.7m)
WACC = 9.85% (E(2.31b)/V(2.33b) * Re(9.91%) + D(13.3m)/V(2.33b) * Rd(0.0%) * (1-Tc(0.10)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 71.91 | Cagr: 10.10%
[DCF] Terminal Value 73.26% ; FCFF base≈93.4m ; Y1≈107.1m ; Y5≈157.6m
[DCF] Fair Price = 10.88 (EV 1.87b - Net Debt -430.9m = Equity 2.31b / Shares 212.0m; r=9.85% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.46 | # QB: 0
Revenue Correlation: 99.79 | Revenue CAGR: 23.28% | SUE: 0.04 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.08 | Chg30d=-4.51% | Revisions=-56% | Analysts=12
EPS next Quarter (2026-09-30): EPS=0.11 | Chg30d=+3.30% | Revisions=+56% | Analysts=12
EPS current Year (2026-12-31): EPS=0.40 | Chg30d=+7.34% | Revisions=+73% | GrowthEPS=+26.7% | GrowthRev=+22.2%
EPS next Year (2027-12-31): EPS=0.50 | Chg30d=+2.20% | Revisions=+29% | GrowthEPS=+23.2% | GrowthRev=+20.2%
[Analyst] Revisions Ratio: +73%